Added AI-powered lung cancer screening analysis software from the Korean company Coreline Soft Medical AI platform Global pharmaceutical company Bayer.
Its flagship product, Aview LCS, is currently one of Bayer’s vendor-neutral, cloud-based markets, and a choice of medical imaging AI software offered by Calantic, along with solutions similar to fellow Korean company Lunit. US2.AI in Singapore.
Calantic is a SAAS platform that allows healthcare providers to select and utilize multiple AI applications from a variety of providers and resolve contracts in one place.
Why is it important?
With this inclusion in Calantic, Coreline Soft can supply lung cancer imaging AI software to governments and local hospitals in Europe.
Korean companies have specific plans to expand further in Germany through a partnership with Bayer. Currently, it has an exclusive supply agreement with the German government for Hanse, a screening trial for lung cancer. The company is also meeting with local hospitals in Europe for supply transactions.
Bigger trends
Since becoming In 2023, Coreline Soft, a public company, has been actively expanding around the world. In Europe, Coreline Soft secures supply contracts in hospitals in France, Spain, Switzerland and Austria.
This year, it made that path China and Australia through local partnerships. He also received assistance from fellow Koreans and a rival in medical imaging AI, by selling AI-powered lung disease diagnosis support software and business.
Meanwhile, this year we obtained 10th and 11th 510(k) clearances from the US Food and Drug Administration for AI-driven diagnostic support solutions for coronary artery disease and upgraded medical imaging analysis platforms. Aview 2.0 each.
